<DOC>
	<DOC>NCT00447811</DOC>
	<brief_summary>This is a study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of MOA-728 in subjects on stable methadone maintenance.</brief_summary>
	<brief_title>Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance</brief_title>
	<detailed_description />
	<mesh_term>Methadone</mesh_term>
	<criteria>History of methadone treatment for at least 1 month before day 1 at a dose of â‰¥ 30 mg/day, and a positive drug test result for methadone. Healthy as determined by the investigator on the basis of screening evaluations. Allergy to opioids (eg, codeine, morphine, or oxymorphone) or opioid antagonists (eg, naloxone or naltrexone). Any significant cardiovascular, hepatic, renal, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Methadone</keyword>
</DOC>